JP2015519303A - 医療機器に新規の抗菌コーティング材を塗布するシステムおよび方法 - Google Patents
医療機器に新規の抗菌コーティング材を塗布するシステムおよび方法 Download PDFInfo
- Publication number
- JP2015519303A JP2015519303A JP2015504632A JP2015504632A JP2015519303A JP 2015519303 A JP2015519303 A JP 2015519303A JP 2015504632 A JP2015504632 A JP 2015504632A JP 2015504632 A JP2015504632 A JP 2015504632A JP 2015519303 A JP2015519303 A JP 2015519303A
- Authority
- JP
- Japan
- Prior art keywords
- alcohol
- medical device
- biocide
- chlorhexidine
- lubricant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 133
- 238000000034 method Methods 0.000 title claims abstract description 42
- 238000000576 coating method Methods 0.000 title claims description 12
- 239000000203 mixture Substances 0.000 claims abstract description 174
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000003139 biocide Substances 0.000 claims abstract description 70
- 230000003115 biocidal effect Effects 0.000 claims abstract description 58
- 239000002904 solvent Substances 0.000 claims abstract description 58
- 239000000314 lubricant Substances 0.000 claims abstract description 49
- 239000004599 antimicrobial Substances 0.000 claims abstract description 29
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims abstract description 16
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims abstract description 15
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 32
- 230000000844 anti-bacterial effect Effects 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 14
- 150000001298 alcohols Chemical class 0.000 claims description 11
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 claims description 9
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 9
- 229960003500 triclosan Drugs 0.000 claims description 8
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 7
- 229960003260 chlorhexidine Drugs 0.000 claims description 7
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000007664 blowing Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229960005443 chloroxylenol Drugs 0.000 claims description 6
- 229960003742 phenol Drugs 0.000 claims description 6
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 claims description 5
- IWYNVAJACBPVLT-UHFFFAOYSA-N 1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine;diacetate Chemical compound CC([O-])=O.CC([O-])=O.C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 IWYNVAJACBPVLT-UHFFFAOYSA-N 0.000 claims description 5
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 5
- 229960001716 benzalkonium Drugs 0.000 claims description 5
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 5
- 229960001950 benzethonium chloride Drugs 0.000 claims description 5
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 claims description 5
- 229960002798 cetrimide Drugs 0.000 claims description 5
- WDRFFJWBUDTUCA-UHFFFAOYSA-N chlorhexidine acetate Chemical compound CC(O)=O.CC(O)=O.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WDRFFJWBUDTUCA-UHFFFAOYSA-N 0.000 claims description 5
- 229960001884 chlorhexidine diacetate Drugs 0.000 claims description 5
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 5
- 229960004867 hexetidine Drugs 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims description 5
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 5
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 4
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 4
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 claims description 4
- 238000005192 partition Methods 0.000 claims description 4
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- 238000001704 evaporation Methods 0.000 abstract description 9
- 230000008020 evaporation Effects 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 6
- 244000052769 pathogen Species 0.000 description 20
- 239000000463 material Substances 0.000 description 13
- 238000001802 infusion Methods 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 206010040047 Sepsis Diseases 0.000 description 7
- 208000037815 bloodstream infection Diseases 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 5
- 210000005166 vasculature Anatomy 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000005456 alcohol based solvent Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012459 cleaning agent Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001775 anti-pathogenic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- CBRUQZUHJAXNHS-UHFFFAOYSA-M 1-hexadecylpyridin-1-ium;acetate Chemical compound CC([O-])=O.CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 CBRUQZUHJAXNHS-UHFFFAOYSA-M 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000032840 Catheter-Related Infections Diseases 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229960002215 cetylpyridinium acetate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
- A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/232—Solid substances, e.g. granules, powders, blocks, tablets layered or coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/235—Solid substances, e.g. granules, powders, blocks, tablets cellular, porous or foamed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/10—Materials for lubricating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0205—Materials having antiseptic or antimicrobial properties, e.g. silver compounds, rubber with sterilising agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M39/16—Tube connectors; Tube couplings having provision for disinfection or sterilisation
- A61M39/162—Tube connectors; Tube couplings having provision for disinfection or sterilisation with antiseptic agent incorporated within the connector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49885—Assembling or joining with coating before or during assembling
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (20)
- ノンアルコール殺生剤と、
潤滑剤と、
アルコールを含む担体溶媒であり、前記殺生剤および前記潤滑剤を溶解することができる、担体溶媒と
を含むことを特徴とする抗菌化合物。 - 前記潤滑剤は低粘度シロキサンを含むことを特徴とする請求項1に記載の抗菌化合物。
- 前記アルコールを含む担体溶媒は、エタノール、イソプロパノール、プロパノール、ブタノール、およびそれらの組合せから成る群から選択されるアルコールを含むことを特徴とする請求項1に記載の抗菌化合物。
- 前記アルコールを含む担体溶媒は、約1個から約6個までの炭素原子の低級アルコールから成る群から選択されることを特徴とする請求項1に記載の抗菌化合物。
- 前記低級アルコールは、約1:10から約1:1までの比率のイソプロパノールとエタノールの混合物を含むことを特徴とする請求項4に記載の抗菌化合物。
- 前記アルコールを含む担体溶媒は、前記抗菌化合物の約70重量%から約99.8重量%までを占めることを特徴とする請求項1に記載の抗菌化合物。
- 前記ノンアルコール殺生剤は、フェノール、第4級アンモニウム、グアニジン、ピリジニウム、ベンザルコニウム、セトリミド、ヘキセチジン、塩化ベンゼトニウム、塩化セチルピリジニウム、酢酸デカリニウム、塩化デカリニウム、クロロキシレノール、クロルヘキシジン、グルコン酸クロルヘキシジン、塩酸クロルヘキシジン、トリクロサン、クロルヘキシジン二塩酸塩、二酢酸クロルヘキシジン、およびそれらの組合せから成る群から選択されることを特徴とする請求項1に記載の抗菌化合物。
- 前記ノンアルコール殺生剤は、前記抗菌化合物の約0.01重量%から約1.0重量%までを占めることを特徴とする請求項1に記載の抗菌化合物。
- 前記ノンアルコール殺生剤は、前記抗菌化合物の約0.01重量%から約0.5重量%までを占めることを特徴とする請求項8に記載の抗菌化合物。
- 前記潤滑剤は約20mN/mの表面張力を含むことを特徴とする請求項1に記載の抗菌化合物。
- 医療機器を組み立てる方法であって、
内腔を有する前記医療機器を設けるステップと、
外面を有する隔壁を設けるステップと、
過剰な抗菌化合物で前記隔壁の前記外面をコーティングするステップであり、前記抗菌化合物は、
ノンアルコール殺生剤、
潤滑剤、および
アルコールを含む担体溶媒であり、前記殺生剤および前記潤滑剤を溶解することができる、担体溶媒、
を含む、コーティングするステップと、
前記コーティングされた隔壁を前記医療機器の前記内腔内に挿入するステップと、
前記コーティングされた隔壁を前進させることおよびそれを前記内腔内に据え付けることにより、前記過剰な抗菌化合物を前記内腔に撒布するステップと、
前記内腔および前記据え付けられた隔壁を通して空気を吹くことにより、前記内腔内で前記過剰な抗菌化合物をさらに撒布するステップと、
前記内腔および前記据え付けられた隔壁を通して追加の空気を吹いて、前記抗菌化合物の前記担体溶媒を蒸発させ、それにより前記潤滑剤および前記ノンアルコール殺生剤を前記内腔の内部に固定するステップと
を含むことを特徴とする方法。 - 前記医療機器はカテーテル組立体であることを特徴とする請求項11に記載の方法。
- 前記潤滑剤は低粘度シロキサンを含むことを特徴とする請求項11に記載の方法。
- 前記アルコールを含む担体溶媒は、エタノール、イソプロパノール、プロパノール、ブタノール、およびそれらの組合せから成る群から選択されるアルコールを含むことを特徴とする請求項11に記載の方法。
- 前記ノンアルコール殺生剤は、フェノール、第4級アンモニウム、グアニジン、ピリジニウム、ベンザルコニウム、セトリミド、ヘキセチジン、塩化ベンゼトニウム、塩化セチルピリジニウム、酢酸デカリニウム、塩化デカリニウム、クロロキシレノール、クロルヘキシジン、グルコン酸クロルヘキシジン、塩酸クロルヘキシジン、トリクロサン、クロルヘキシジン二塩酸塩、二酢酸クロルヘキシジン、およびそれらの組合せから成る群から選択されることを特徴とする請求項11に記載の方法。
- 前記アルコールを含む担体溶媒は約1個から約6個までの炭素原子の低級アルコールから成る群から選択されることを特徴とする請求項11に記載の方法。
- 前記低級アルコールは、約1:10から約1:1までの比率のイソプロパノールとエタノールの混合物を含むことを特徴とする請求項16に記載の方法。
- 前記ノンアルコール殺生剤は、前記抗菌化合物の約0.01重量%から約1.0重量%までを占めることを特徴とする請求項11に記載の方法。
- 抗菌組成物であって、
グルコン酸クロルヘキシジンを含むノンアルコール殺生剤であり、前記グルコン酸クロルヘキシジンは前記抗菌組成物の約0.01重量%から約0.5重量%までを占める、ノンアルコール殺生剤と、
低粘度シロキサンを含む潤滑剤と、
アルコールを含む担体溶媒であり、前記殺生剤および前記潤滑剤を溶解することができ、前記アルコールは、約1:10から約1:1までの比率のイソプロパノールとエタノールの混合物を含む、アルコールを含む担体溶媒と
を含むことを特徴とする抗菌組成物。 - フェノール、第4級アンモニウム、グアニジン、ピリジニウム、ベンザルコニウム、セトリミド、ヘキセチジン、塩化ベンゼトニウム、塩化セチルピリジニウム、酢酸デカリニウム、塩化デカリニウム、クロロキシレノール、クロルヘキシジン、塩酸クロルヘキシジン、トリクロサン、クロルヘキシジン二塩酸塩、二酢酸クロルヘキシジン、およびそれらの組合せから成る群から選択される第2のノンアルコール殺生剤をさらに含むことを特徴とする請求項19に記載の抗菌組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/438,559 | 2012-04-03 | ||
US13/438,559 US20130255061A1 (en) | 2012-04-03 | 2012-04-03 | Systems and methods for applying a novel antimicrobial coating material to a medical device |
PCT/US2013/034356 WO2013151860A1 (en) | 2012-04-03 | 2013-03-28 | Systems and methods for applying a novel antimicrobial coating material to a medical device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017101698A Division JP6557283B2 (ja) | 2012-04-03 | 2017-05-23 | 静脈内医療機器 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015519303A true JP2015519303A (ja) | 2015-07-09 |
JP6150880B2 JP6150880B2 (ja) | 2017-06-21 |
Family
ID=48096303
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015504632A Active JP6150880B2 (ja) | 2012-04-03 | 2013-03-28 | 医療機器に新規の抗菌コーティング材を塗布するシステムおよび方法 |
JP2017101698A Active JP6557283B2 (ja) | 2012-04-03 | 2017-05-23 | 静脈内医療機器 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017101698A Active JP6557283B2 (ja) | 2012-04-03 | 2017-05-23 | 静脈内医療機器 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20130255061A1 (ja) |
EP (2) | EP2833720B1 (ja) |
JP (2) | JP6150880B2 (ja) |
CN (2) | CN104349671B (ja) |
AU (1) | AU2013243777B2 (ja) |
BR (1) | BR112014024742B1 (ja) |
CA (1) | CA2869015C (ja) |
ES (1) | ES2961963T3 (ja) |
MX (1) | MX2014011809A (ja) |
WO (1) | WO2013151860A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017153995A (ja) * | 2012-04-03 | 2017-09-07 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | 静脈内医療機器 |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
US10589063B2 (en) | 2014-04-23 | 2020-03-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US11219705B2 (en) | 2014-07-08 | 2022-01-11 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
US11357962B2 (en) | 2013-02-13 | 2022-06-14 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9078992B2 (en) * | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
US20150141965A1 (en) * | 2013-11-15 | 2015-05-21 | Celeste V. Bonham | Tubing for mitigating against microbial migration and method and system for maintaining closed-system of urinary tubing |
US10792398B2 (en) * | 2014-02-20 | 2020-10-06 | Becton, Dickinson And Company | Antimicrobial inserts for medical devices |
US9675793B2 (en) * | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
US10610677B2 (en) | 2014-05-19 | 2020-04-07 | Celeste V. Bonham | Urological system that includes connector with integrated non-return check valve for extension tubing and urology collection systems |
CN106280977B (zh) * | 2015-05-21 | 2019-12-27 | 福州维亚生物科技有限公司 | 一种硅橡胶抗菌涂层 |
EP3341358B1 (en) | 2015-08-27 | 2023-03-08 | Nano Safe Coatings Incorporated (a Florida Corporation 3 P 14000024914) | Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials |
WO2018013805A2 (en) | 2016-07-14 | 2018-01-18 | Hollister Incorporated | Hygienic medical devices having hydrophilic coating and methods of forming the same |
GB201621050D0 (en) * | 2016-12-12 | 2017-01-25 | Provita Eurotech Ltd | Antimicrobial compositions |
US11052234B2 (en) | 2017-02-15 | 2021-07-06 | Celeste V. Bonham | Connector with integrated non-return check valve for extension tubing and urology collection systems |
CN112827775A (zh) * | 2021-01-05 | 2021-05-25 | 安徽郁金香新能源科技有限公司 | 一种新型高效地源热泵地埋管防生物菌沉积方法 |
WO2024015353A1 (en) * | 2022-07-12 | 2024-01-18 | Becton, Dickinson And Company | Instrument delivery system with antimicrobial features |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02234764A (ja) * | 1989-01-18 | 1990-09-17 | Becton Dickinson & Co | 抗感染性および潤滑性医療用品ならびにそれらの製法 |
JPH0747435A (ja) * | 1993-08-06 | 1995-02-21 | Honda Motor Co Ltd | 隔壁付き中空体及びその製造方法 |
JPH0840883A (ja) * | 1994-06-27 | 1996-02-13 | Becton Dickinson & Co | 皮膚消毒剤 |
JPH11322560A (ja) * | 1998-01-20 | 1999-11-24 | Ethicon Inc | 抗微生物組成物 |
JP2008512389A (ja) * | 2004-09-07 | 2008-04-24 | スリーエム イノベイティブ プロパティズ カンパニー | カチオン性消毒剤組成物および使用方法 |
JP2008533051A (ja) * | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 微小生体汚染の低減方法 |
JP2009527356A (ja) * | 2006-02-23 | 2009-07-30 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 除去可能な抗菌性コーティング組成物およびその使用方法 |
JP2009528360A (ja) * | 2006-02-28 | 2009-08-06 | ベクトン・ディキンソン・アンド・カンパニー | 抗菌性組成物及び固定型カテーテルのための方法 |
JP2010536836A (ja) * | 2007-08-24 | 2010-12-02 | インサイト ヘルス リミテッド | 殺菌剤 |
WO2011005951A2 (en) * | 2009-07-09 | 2011-01-13 | Becton, Dickinson And Company | Antimicrobial coating for dermally invasive devices |
WO2011034675A2 (en) * | 2009-09-17 | 2011-03-24 | Becton, Dickinson And Company | Anti-infective lubricant for medical devices and methods for preparing the same |
WO2012036916A1 (en) * | 2010-09-13 | 2012-03-22 | Becton, Dickinson And Company | A catheter assembly |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019096A (en) * | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
US5670111A (en) * | 1990-01-10 | 1997-09-23 | Rochester Medical Corporation | Method of shaping structures with an overcoat layer including female urinary catheter |
US5357636A (en) * | 1992-06-30 | 1994-10-25 | Dresdner Jr Karl P | Flexible protective medical gloves and methods for their use |
US6046143A (en) * | 1994-08-22 | 2000-04-04 | Becton Dickinson And Company | Water soluble lubricant for medical devices |
CA2154112C (en) * | 1994-08-22 | 2000-09-26 | Mohammad A. Khan | Water soluble lubricant for medical devices |
CN1187598A (zh) * | 1996-12-09 | 1998-07-15 | 贝克顿迪金森公司 | 特氟隆产品的水溶性润滑剂 |
US20020022660A1 (en) * | 1998-01-20 | 2002-02-21 | Hanuman B. Jampani | Deep penetrating antimicrobial compositions |
US6344218B1 (en) * | 1998-11-23 | 2002-02-05 | The Procter & Gamble Company | Skin deodorizing and santizing compositions |
US7179849B2 (en) * | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
US6818247B1 (en) * | 2000-03-31 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent |
DE10041684A1 (de) * | 2000-08-24 | 2002-03-07 | Inst Textil & Faserforschung | Beschichtungsmaterial zur medizinischen Behandlung aus resorbierbarem synthetischem Material, Verfahren zu seiner Herstellung und Verwendung in der Medizin |
US7329412B2 (en) * | 2000-12-22 | 2008-02-12 | The Trustees Of Columbia University In The City Of New York | Antimicrobial medical devices containing chlorhexidine free base and salt |
CA2466506C (en) * | 2001-11-13 | 2012-10-23 | Becton, Dickinson And Company | Spray dry process for applying anticoagulant on a syringe barrel |
MXPA06000543A (es) * | 2003-07-17 | 2006-03-30 | Univ Columbia | Composiciones antimicrobianas que contienen combinaciones sinergicas de compuestos de amonio cuaternario y aceites esenciales y/o constituyentes de estos. |
US7651990B2 (en) * | 2005-06-13 | 2010-01-26 | 3M Innovative Properties Company | Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use |
US8343523B2 (en) * | 2005-08-22 | 2013-01-01 | Quick-Med Technologies, Inc. | Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers |
WO2007070801A2 (en) * | 2005-12-12 | 2007-06-21 | Allaccem, Inc. | Methods and systems for preparing antimicrobial films and coatings |
WO2008148013A1 (en) * | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
US8622996B2 (en) * | 2008-10-27 | 2014-01-07 | Pursuit Vascular, Inc. | Method for applying antimicrobial to proximal end of catheter |
US20100135949A1 (en) * | 2008-12-01 | 2010-06-03 | Becton, Dickinson And Company | Antimicrobial compositions |
US7704935B1 (en) * | 2009-01-06 | 2010-04-27 | Becton, Dickinson And Company | Chlorhexidine acetate antiseptic cleaning agent |
US8469928B2 (en) * | 2009-02-11 | 2013-06-25 | Becton, Dickinson And Company | Systems and methods for providing a flushable catheter assembly |
US8343525B2 (en) * | 2009-12-22 | 2013-01-01 | Becton, Dickinson And Company | Chlorhexidine acetate antiseptic cleaning agent |
US20130255061A1 (en) * | 2012-04-03 | 2013-10-03 | Becton, Dickinson And Company | Systems and methods for applying a novel antimicrobial coating material to a medical device |
-
2012
- 2012-04-03 US US13/438,559 patent/US20130255061A1/en not_active Abandoned
-
2013
- 2013-03-28 CA CA2869015A patent/CA2869015C/en active Active
- 2013-03-28 EP EP13716643.5A patent/EP2833720B1/en active Active
- 2013-03-28 AU AU2013243777A patent/AU2013243777B2/en active Active
- 2013-03-28 BR BR112014024742-0A patent/BR112014024742B1/pt active IP Right Grant
- 2013-03-28 CN CN201380024389.7A patent/CN104349671B/zh active Active
- 2013-03-28 JP JP2015504632A patent/JP6150880B2/ja active Active
- 2013-03-28 MX MX2014011809A patent/MX2014011809A/es active IP Right Grant
- 2013-03-28 WO PCT/US2013/034356 patent/WO2013151860A1/en active Application Filing
- 2013-03-28 ES ES13716643T patent/ES2961963T3/es active Active
- 2013-03-28 EP EP23195144.3A patent/EP4302789A3/en active Pending
- 2013-03-28 CN CN201810881763.XA patent/CN108939170B/zh active Active
-
2014
- 2014-03-31 US US14/231,344 patent/US20140200523A1/en not_active Abandoned
-
2017
- 2017-05-23 JP JP2017101698A patent/JP6557283B2/ja active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02234764A (ja) * | 1989-01-18 | 1990-09-17 | Becton Dickinson & Co | 抗感染性および潤滑性医療用品ならびにそれらの製法 |
JPH0747435A (ja) * | 1993-08-06 | 1995-02-21 | Honda Motor Co Ltd | 隔壁付き中空体及びその製造方法 |
JPH0840883A (ja) * | 1994-06-27 | 1996-02-13 | Becton Dickinson & Co | 皮膚消毒剤 |
JPH11322560A (ja) * | 1998-01-20 | 1999-11-24 | Ethicon Inc | 抗微生物組成物 |
JP2008512389A (ja) * | 2004-09-07 | 2008-04-24 | スリーエム イノベイティブ プロパティズ カンパニー | カチオン性消毒剤組成物および使用方法 |
JP2008533051A (ja) * | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 微小生体汚染の低減方法 |
JP2009527356A (ja) * | 2006-02-23 | 2009-07-30 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 除去可能な抗菌性コーティング組成物およびその使用方法 |
JP2009528360A (ja) * | 2006-02-28 | 2009-08-06 | ベクトン・ディキンソン・アンド・カンパニー | 抗菌性組成物及び固定型カテーテルのための方法 |
JP2010536836A (ja) * | 2007-08-24 | 2010-12-02 | インサイト ヘルス リミテッド | 殺菌剤 |
WO2011005951A2 (en) * | 2009-07-09 | 2011-01-13 | Becton, Dickinson And Company | Antimicrobial coating for dermally invasive devices |
WO2011034675A2 (en) * | 2009-09-17 | 2011-03-24 | Becton, Dickinson And Company | Anti-infective lubricant for medical devices and methods for preparing the same |
WO2012036916A1 (en) * | 2010-09-13 | 2012-03-22 | Becton, Dickinson And Company | A catheter assembly |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017153995A (ja) * | 2012-04-03 | 2017-09-07 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | 静脈内医療機器 |
US11357962B2 (en) | 2013-02-13 | 2022-06-14 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US10589063B2 (en) | 2014-04-23 | 2020-03-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US11357965B2 (en) | 2014-04-23 | 2022-06-14 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US11219705B2 (en) | 2014-07-08 | 2022-01-11 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
US11904114B2 (en) | 2015-10-28 | 2024-02-20 | Becton, Dickinson And Company | Extension tubing strain relief |
Also Published As
Publication number | Publication date |
---|---|
AU2013243777A1 (en) | 2014-10-16 |
CN108939170A (zh) | 2018-12-07 |
US20130255061A1 (en) | 2013-10-03 |
EP2833720C0 (en) | 2023-09-06 |
EP2833720B1 (en) | 2023-09-06 |
JP6150880B2 (ja) | 2017-06-21 |
MX2014011809A (es) | 2014-12-05 |
EP4302789A3 (en) | 2024-03-27 |
CA2869015C (en) | 2020-01-14 |
JP2017153995A (ja) | 2017-09-07 |
CN108939170B (zh) | 2021-11-30 |
US20140200523A1 (en) | 2014-07-17 |
CA2869015A1 (en) | 2013-10-10 |
WO2013151860A1 (en) | 2013-10-10 |
EP2833720A1 (en) | 2015-02-11 |
CN104349671B (zh) | 2018-09-04 |
ES2961963T3 (es) | 2024-03-14 |
CN104349671A (zh) | 2015-02-11 |
BR112014024742B1 (pt) | 2019-10-01 |
JP6557283B2 (ja) | 2019-08-07 |
AU2013243777B2 (en) | 2016-11-24 |
EP4302789A2 (en) | 2024-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6557283B2 (ja) | 静脈内医療機器 | |
AU2010295926B2 (en) | Anti-infective lubricant for medical devices and methods for preparing the same | |
AU2009335672B2 (en) | Chlorhexidine acetate antiseptic cleaning agent | |
AU2018201639B2 (en) | Blood control catheter with antimicrobial needle lube | |
JP5998051B2 (ja) | 皮膚を介した侵襲装置のための抗菌被覆 | |
US8343525B2 (en) | Chlorhexidine acetate antiseptic cleaning agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160317 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160817 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170208 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170328 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170427 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170523 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6150880 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |